Search - tctmd.com

Displaying 1 - 4 of 4

Sort: Relevancy | Date

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Presentation

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Presenter: Emerson C. Perin

January 27, 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

AMICI: Use of Mesenchymal Precursor Cells in the Treatment of STEMI Patients (FIM/IIB Study)

Presentation TCT 2012

AMICI: Use of Mesenchymal Precursor Cells in the Treatment of STEMI Patients (FIM/IIB Study)

Presenter: Henricus Duckers

October 22, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.